Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy

Gynecologic Oncology

Volumn 93, Issue 2, 2004, Pages 458-464

  Ho, Chih Ming ^a,c   Chien, Tsai Yen ^a   Huang, Shih Hung ^a   Wu, Ching Jung ^b   Shih, Bor Yuan ^a   Chang, Shang Che ^a  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Cervical carcinoma; Prognostic factor; Radical hysterectomy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER RECURRENCE; CANCER RESEARCH; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CELL TYPE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL RECORD; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PATIENT SELECTION; PELVIS LYMPHADENECTOMY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RADICAL HYSTERECTOMY; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; TUMOR VOLUME; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; MULTIVARIATE ANALYSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 1942444570     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.01.026     Document Type: Article

References (30)

1. Kenneth D.H., Fu Y.S. Cervical and vaginal cancer. Berek J.S., Adashi E.Y., Hillard P.A. Novak's Gynecology. 12th edition:1996;1111-1153 Williams & Wilkins, Baltimore, MD.
2. Landoni F., Maneo A., Lolombo A., Placa F., Milani R., Perego P.et al. Randomized study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet. 350:1997;535-540.
3. Boyce J.G., Fruchter R.G., Nicastri A.A.D., Roberta H.D., Ambiavagar P.C., Reinis M.et al. Vascular invasion in stage I carcinoma of the cervix. Cancer. 53:1984;1175-1180.
4. Zreik T.G., Chambers J.T., Chambers S.K. Parametrial involvement, regardless of nodal status: a poor prognostic factor for cervical cancer. Obstet. Gynecol. 87:1996;741-746.
5. Delgado G., Bundy B., Zaino R., Sevin B.U., Creasman W.T., Major F. Prospective surgical-pathological study of disease-free interval in patients with stage Ib squamous cell carcinoma of the cervix: a gynecologic oncology group study. Gynecol. Oncol. 38:1990;352-357.
6. Sevin B.U., Lu Y., Bloch D., Nadji M., Koechli O.R., Averette H.E. Surgically defined prognostic parameters in patients with early cervical carcinoma. Cancer. 78:1996;1438-1446.
7. Kamura T., Tsukamoto N., Tsuruchi N., Saito T., Matsuyama T., Akazawa K.et al. Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy. Cancer. 69:1992;181-186.
8. Piver M.S., Chung W.S. Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma. Obstet. Gynecol. 46:1975;507-510.
9. Estape R.E., Angioli R., Madrigal M., Janicek M., Gomez C., Penalver M.et al. Close vaginal margins as a prognostic factor after radical hysterectomy. Gynecol. Oncol. 68:1998;229-232.
10. Ho C.M., Chien T.Y., Shih B.Y., Huang S.H. Evaluation of complete surgical staging with pelvic and para-aortic lymphadenectomy and paclitaxel plus carboplatin chemotherapy for improvement of survival in stage I ovarian clear cell carcinoma. Gynecol. Oncol. 88:2003;394-399.
11. FIGO Cancer Committee Staging announcement. Gynecol. Oncol. 8:1986;353-385.
12. Cox D.R. Regression models and life tables. J. R. Stat. Soc., B. 34:1972;187-220.
13. 1-2 cervical carcinoma. Cancer. 97:2003;1904-1908.
14. Harrel F.E., Lee K.L., Matchar D.B., Reichert T.A. Regression models for prognostic prediction: advantages, problem, and suggested solution. Cancer Treat. Rep. 69:1985;1071-1077.
15. Inoue T., Mortia K. The prognostic significance of number of positive nodes in cervical carcinoma stage IB, IIA, IIB. Cancer. 65:1990;1923-1927.
16. Hsu C., Cheng Y., Su S. Prognosis of uterine cervical cancer with extensive lymph node metastases. Am. J. Obstet. Gynecol. 114:1972;954-962.
17. Burghardt E., Pickel H., Haas J., Lahousen M. Prognostic factors and operative treatment of stage IB to IIB cervical cancer. Am. J. Obstet. Gynecol. 156:1987;988-996.
18. Fuller A.F., Elliot N., Kosloff C., Lewis J.L. Jr. Lymph node metastases from carcinoma of the cervix, stage IB and IIA: implications for prognosis and treatment. Gynecol. Oncol. 13:1982;164-174.
19. Sevin B.U., Nadji M., Lampe B., Lu Y., Hilsenbeck S., Koechli O.R.et al. Prognostic factors of early stage cervical cancer treated by radical hysterectomy. Cancer. 76:1995;1978-1986.
20. Friedberg V. Operative therapy for stage IIb cervical cancer. Burghard E., Monaghan J.M. Operative Treatment of Cervical Cancer. Bailliere's Clinical Obstetrics and Gynaecology. vol. 2/4:1988;973-980 Bailliere Tindall, Eastbourne, UK.
21. Chung C.K., Nahhas W.A., Stryker J.A., Curry S.L., Abt A.B., Mortel R. Analysis of factors contributing to treatment failures in stage IB and IIA carcinoma of the cervix. Am. J. Obstet. Gynecol. 138:1980;550-556.
22. Van Nagell J.R., Donaldson E.S., Wood E., Parker J. The significance of vascular invasion and lymphocytic infiltration in invasive cervical cancer. Cancer. 41:1978;228-234.
23. Hachisuga T., Kaku T., Fukuda K., Emoto M., Kamura T., Iwasaka T.et al. The grading of lymphovascular space invasion in endometrial carcinoma. Cancer. 86:1999;2090-2097.
24. Inoue Y., Obata K., Abe K., Ohmura G., Doh K., Yoshioka T.et al. The prognostic significance of vascular invasion by endometrial carcinoma. Cancer. 78:1996;1447-1451.
25. Barber H., Sommers S.C., Rotterdam H., Kwon T. Vascular invasion as a prognostic factor in stage IB cancer of the cervix. Obstet. Gynecol. 52:1978;343-348.
26. Abdulhayoglu S., Rich W.M., Renold J., DiSaia P.J. Selective radiation therapy in stage IB uterine cervical carcinoma following radical pelvic surgery. Gynecol. Oncol. 10:1980;84-92.
27. Boyce J., Fruchter R.G., Nicastri A., Curry S.L., Ambiavagar P., Reinis M.S.et al. Prognostic factors in stage I carcinoma of the cervix. Gynecol. Oncol. 12:1981;154-165.
28. Morrow C.P. Is pelvic radiation beneficial in the postoperative management of stage IB squamous cell carcinoma of the cervix with pelvic node metastasis treated by radical hysterectomy and pelvic lymphadenectomy? Gynecol. Oncol. 10:1980;105-110.
29. Kinney W.K., Alvarez R.D., Reid G.C., Schray M.F., Soong S.J., Morley G.W.et al. Value of adjuvant whole-pelvis irradiation after Wertheim hysterectomy for early-stage squamous carcinoma of the cervix with pelvic nodal metastasis: a matched-control study. Gynecol. Oncol. 34:1989;258-262.
30. Peters W.A. III, Liu P.Y., Barrett R.J. II, Stock R.J., Monk B.J., Berek J.S.et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J. Clin. Oncol. 18:2000;1606-1613.